Rett Syndrome Treatment TSHA-102 Received Rare Pediatric Disease and Orphan Drug Designations
Recently, gene therapy company Taysha Gene Therapies ("Taysha") announced that its gene therapy candidate, TSHA-102, received both Orphan Drug and Rare Pediatric Disease designations from the FDA. TSHA-102, delivered via…